Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2010 Aug;102(8):676-82.
doi: 10.1016/s0027-9684(15)30652-0.

Primary care clinicians' knowledge and confidence about newborn screening for sickle cell disease: randomized assessment of educational strategies

Suzette O Oyeku  1 , Henry A Feldman, Kathleen Ryan, Sharon Muret-Wagstaff, Ellis J Neufeld
Affiliations
Randomized Controlled Trial

Primary care clinicians' knowledge and confidence about newborn screening for sickle cell disease: randomized assessment of educational strategies

Suzette O Oyeku et al. J Natl Med Assoc. 2010 Aug.

Abstract

Objective: In Massachusetts, primary care clinicians receive and act upon hemoglobinopathy newborn screening results. We assessed clinicians' knowledge, confidence, and practices regarding hemoglobinopathy newborn screening, and the effect of mailed educational materials vs interactive seminar on knowledge and confidence.

Methods: A randomized educational intervention trial was performed at 15 community health sites. Practices were randomized to determine the order in which the educational interventions were administered: mailed educational materials first or interactive seminars on the management of hemoglobinopathy newborn screening results first. Clinicians' demographics, knowledge, confidence, and practices were assessed by a survey. Posttests were administered soon after the intervention.

Results: Responses came from 85 of 170 eligible providers (50%). Twenty-nine percent of respondents provided both pretests and posttests. In respondents with paired data, knowledge on a 5-point scale improved by 1.4 +/- 0.4 (mean +/- standard error of the mean, p = .003), while self-efficacy on a 16-point scale increased by 1.3 +/- 0.3, p = .002. There were no significant differences between seminar and mailed-materials groups.

Conclusions: Both educational strategies led to modest improvements in knowledge about newborn screening for hemoglobin disorders. Enhancing knowledge and confidence about newborn screening-related tasks may improve clinicians' capacity to act upon newborn screening results for hemoglobinopathies.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Scores (Mean ± Standard Deviation) of Primary Care Clinicians’ Preintervention and Postinterventiona a All baseline and follow-up responses are included (N = 85).
See this image and copyright information in PMC

References

    1. Consensus conference. Newborn screening for sickle cell disease and other hemoglobinopathies. JAMA. 1987;258(9):1205–1209. - PubMed
    1. National Newborn Screening and Genetics Resource Center. [Accessed March 20, 2009];National Newborn Screening Status Report. http://genes-r-us.uthscsa.edu/nbsdisorders.pdf.
    1. US Preventive Services Task Force. [Accessed March 20, 2009];Screening for Sickle Cell Disease in Newborns: US Preventive Services Task Force Recommendation Statement. AHRQ Publication. No. 07-05104-EF-2. www.ahrq.gov/clinic/uspstf07/sicklecell/sicklers.htm.
    1. Pass KA, Lane PA, Fernhoff PM, et al. US newborn screening system guidelines II: follow-up of children, diagnosis, management, and evaluation. Statement of the Council of Regional Networks for Genetic Services (CORN) J Pediatr. 2000;137(4 suppl):S1–S46. - PubMed
    1. Kim S, Lloyd-Puryear MA, Tonniges TF. Examination of the communication practices between state newborn screening programs and the medical home. Pediatrics. 2003;111(2):E120–E126. - PubMed

Publication types